Results 111 to 120 of about 28,814 (216)
Improving imiquimod use in cervical high‐grade squamous intraepithelial lesions: A qualitative study
Acta Obstetricia et Gynecologica ScandinavicaIntroduction To investigate patient experiences and satisfaction with imiquimod for cervical high‐grade squamous intraepithelial lesions and its side effects, possibly influencing the (dis)continuation of treatment.
Caroline L. P. Muntinga +9 more
doaj +1 more source
Vestnik Dermatologii i Venerologii, 2017 The aim. investigation of the possibilities of dermatoscopy as a method for evaluating the effectiveness of therapy with topical imiquimod in patients with superficial basal cell carcinoma (CCB). Materials and methods. the study included 24 patients with
M. V. Zhuchkov +3 more
doaj +1 more source
Management of Surgical Margins in the Excision of Oral Leukoplakia: A Scoping Review
Oral Diseases, EarlyView.ABSTRACT Objective To map the literature on management of surgical margins for oral leukoplakia (OL) and proliferative verrucous leukoplakia (PVL). Methods Searches were performed in five electronic databases and gray literature. Studies involving patients undergoing any type of surgical excision of OL or PVL were included.
Mateus José Dutra +8 more
wiley +1 more source
Indian Journal of Dermatology, Venereology and Leprology, 2006 Kruti S, Jobanputra +2 more
openaire +3 more sources
Curcumin Nanoformulations for Dermatological Applications: From Nutraceuticals to Nanocarriers
Food Frontiers, Volume 7, Issue 3, May 2026.Nanotechnology‐based delivery platforms enhance the cutaneous administration of curcumin. Loading free curcumin into polymeric micelles, metal‐based nanoparticles, nanogels/hydrogels, liposomes, polymeric nanoparticles, or nanoemulsions/nanocrystals helps address its low solubility, poor stability and limited skin permeation. As a result, these systems
Stephany Celeste Gutiérrez‐Ruiz +13 more
wiley +1 more source
Taiwanese Journal of Obstetrics & Gynecology, 2013 Objective: To assess the clinical response to imiquimod 5% cream in patients with persistent human papillomavirus (HPV) infection after treatment of genital intraepithelial neoplasia.
Fang-Ping Chen
doaj +1 more source
Advanced NanoBiomed Research, Volume 6, Issue 4, April 2026.This review highlights how autoimmune diseases arise from intertwined immunological, genetic, and environmental factors, emphasizing gut microbiota dysbiosis as a pivotal driver. It outlines emerging nanotechnology‐based strategies—such as liposomes, hydrogels, and polymeric nanoparticles—that enhance targeted drug delivery, minimize systemic toxicity,
Md. Meraj Ansari +5 more
wiley +1 more source
How I treat ... basal cell carcinoma by imiquimod. [PDF]
, 2005 peer reviewedBasal cell carcinoma is the most frequent cancer in humans. Several clinical types are distinguished. They are bound to distinct evolutive prognosis.
Nikkels, Arjen +4 more
core
The Open Reading Frame 7b of the SARS‐CoV‐2 Disperse Trans‐Golgi and Activate the NLRP3 Inflammasome
Journal of Medical Virology, Volume 98, Issue 4, April 2026.ABSTRACT Inflammasomes orchestrate the inflammatory response against bacterial and viral infections, thereby initiating the synthesis of pro‐inflammatory cytokines, mainly IL‐1β and IL‐18. SARS‐CoV‐2 infection induces an inflammatory response mediated by the activation of NLRP1 and NLRP3 inflammasomes.
Julio García‐Villalba +4 more
wiley +1 more source
Disease-Independent Skin Recruitment and Activation of Plasmacytoid Predendritic Cells Following Imiquimod Treatment [PDF]
, 2017 Background: Imiquimod, an immune response modifier that is used topically to treat different types of skin cancer, induces the production of proinflammatory cytokines that stimulate an antitumor immune response.
Beyeler, Mirjam +6 more
core